E. Lieber

发表

Role of CHADS2 score in evaluation of thromboembolic risk and mortality in patients with atrial fibrillation undergoing direct current cardioversion (from the ACUTE Trial Substudy).

A. Klein, H. Yarmohammadi, Sarah J Williams, 2012, The American journal of cardiology.

Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: Initial clinical experience in 1263 patients

M. Cerqueira, R. Brunken, P. Houghtaling, 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.

C. Apperson-Hansen, A. Klein, M. Stoddard, 2008, The American journal of cardiology.

The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre st

C. Apperson-Hansen, A. Klein, M. Stoddard, 2006, European heart journal.

Spontaneous conversion of patients with atrial fibrillation scheduled for electrical cardioversion: an ACUTE trial ancillary study.

R. D. Murray, R. Grimm, C. Apperson-Hansen, 2003, Journal of the American College of Cardiology.

National use of the transesophageal echocardiographic-guided approach to cardioversion for patients in atrial fibrillation.

R. Grimm, M. García, A. Klein, 2000, The American journal of cardiology.

Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trial.

C. Asher, W. Zoghbi, C. Apperson-Hansen, 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.

R. D. Murray, J. Halperin, R. Erbel, 2006, American heart journal.

Predictive value of exercise myocardial perfusion imaging in the Medicare population: the impact of the ability to exercise.

M. Cerqueira, R. Brunken, P. Houghtaling, 2014, Cardiovascular diagnosis and therapy.

Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.

W. Weintraub, A. Klein, Liping Zhao, 2008, American heart journal.

Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.

R. D. Murray, R. Grimm, W. Weintraub, 2004, Journal of the American College of Cardiology.

Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies.

Jianbo Li, R. D. Murray, Carolyn Apperson-Hansen, 2003, The American journal of cardiology.

Impact of cardioversion strategy on functional capacity in patients with atrial fibrillation: the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) study.

R. Grimm, C. Apperson-Hansen, A. Klein, 2005, American heart journal.